<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363331">
  <stage>Registered</stage>
  <submitdate>3/12/2012</submitdate>
  <approvaldate>12/12/2012</approvaldate>
  <actrnumber>ACTRN12612001288819</actrnumber>
  <trial_identification>
    <studytitle>A randomized, double-blind pilot study of Yin-Chen-Hao-Tang in treating obese people with fatty liver</studytitle>
    <scientifictitle>For obese people with fatty liver, dose Yin-Chen-Hao-Tang has effect on fatty liver degree?</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>The use of Yin-Chen-Hao-Tang herbal remedy in treating obese people with fatty liver</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Alternative and Complementary Medicine</conditioncode1>
      <conditioncode2>Herbal remedies</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Yin-Chen-Hao-Tang is a traditional Chinese herbal remedy composed of Artemisia capillaris (Yin Chen), Gardenia jasminoides Ellis (Zhi Zi) and Rheum officinale Baill (Da Huang). Patients were treated with Yin-Chen-Hao-Tang (extract granule; 0.375 gm/capsule; oral use), 4 capsules per time and 3 times per day , the treating course is 8 weeks.</interventions>
    <comparator>placebo capsule (1/100 amount of Yin-Chen-Hao-Tang capsule) is used with the same regimen in controlled group.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>fatty liver degree, as assessed by ultrasonographic stages</outcome>
      <timepoint>baseline and the 8th week</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>blood test for liver function and blood lipid level, including Aspartate transaminase (AST), Alanine aminotransferase (ALT), Gamma-glutamyl transpeptidase (gamma-GT) and triglyceride (TG)</outcome>
      <timepoint>baseline and the 8th week</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>participant who is obese with fatty liver that is diagnosed at  outpatient department</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1.Patient has ALT and AST levels of over 1000 u/L
2.Patient has a-Fetoprotein (AFP) levels of over 2 upper laboratory norms.
3.Patient is pregnant
4.Patients with alcoholic or drug abuse
5.Patients treatment with drugs, e.g. corticosteroids, high-dose estrogens, methotrexate, amiodarone, calcium channel blockers, spironolactone, sulfasalazine, naproxen, or oxacillin.
6.Patient has total cholesterol (TC) and triglyceride (TG) over 300 u/L
7.Patient has fast plasma glucose over 126 mg/dl, and postprandial plasma glucose over 200mg/dl
8.Patient has HBsAg positive
9.Patient has Anti-HCV positive
10.Patient with a malignancy which can influence prognosis
11.Patient has BP less than 90/50 mm/Hg</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>False</masking3>
    <masking4>False</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/04/2011</anticipatedstartdate>
    <actualstartdate>11/04/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Taiwan, Province Of China</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Taoyuan Chang Gung Memorial Hospital of The Chang Gung Medical Fundation</primarysponsorname>
    <primarysponsoraddress>NO.123, DINGHU RD., GUISHAN TOWNSHIP, TAOYUAN COUNTY 333,  TAIWAN, R.O.C.</primarysponsoraddress>
    <primarysponsorcountry>Taiwan, Province Of China</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Taoyuan Chang Gung Memorial Hospital of The Chang Gung Medical Fundation</fundingname>
      <fundingaddress>NO.123, DINGHU RD., GUISHAN TOWNSHIP, TAOYUAN COUNTY 333,  TAIWAN, R.O.C.</fundingaddress>
      <fundingcountry>Taiwan, Province Of China</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Yin-Chen-Hao-Tang is a traditional Chinese herbal remedy that has efficacy in treating jaundice in past study. In this study, we want to see if Yin-Chen-Hao-Tang can improve degree of fatty liver in obesity. Capsule with extract granule of Yin-Chen-Hao-Tang is used in treating group for 8 weeks, placebo with 1/100 amount of Yin-Chen-Hao-Tang capsule is used in controlled group. The degree of fatty liver is assessed by ultrasonography before and after treatment. Liver function and blood lipid level are also evaluated.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Chang Gung Medical Foundation Institutional Review Board</ethicname>
      <ethicaddress>NO.123, DINGHU RD., GUISHAN TOWNSHIP, TAOYUAN COUNTY 333, TAIWAN, R.O.C.</ethicaddress>
      <ethicapprovaldate>1/04/2011</ethicapprovaldate>
      <hrec>99-3538A3</hrec>
      <ethicsubmitdate>1/03/2011</ethicsubmitdate>
      <ethiccountry>Taiwan, Province Of China</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Tzung-Yan Lee</name>
      <address>No.259, Wenhwa 1st Rd, Guishan Township, Taoyuan County 333, Taiwan, R.O.C.</address>
      <phone>+886-3-2118800#3537</phone>
      <fax>+886-3-2118349</fax>
      <email>joyamen@mail.cgu.edu.tw</email>
      <country>Taiwan, Province Of China</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Tzung-Yan Lee</name>
      <address>No.259, Wenhwa 1st Rd, Guishan Township, Taoyuan County 333, Taiwan, R.O.C.</address>
      <phone>+886-3-2118800#3537</phone>
      <fax>+886-3-3294841</fax>
      <email>joyamen@mail.cgu.edu.tw</email>
      <country>Taiwan, Province Of China</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Tzung-Yan Lee</name>
      <address>No.259, Wenhwa 1st Rd, Guishan Township, Taoyuan County 333, Taiwan, R.O.C.</address>
      <phone>+886-3-2118800#3537</phone>
      <fax>+886-3-2118349</fax>
      <email>zac2306@gmail.com</email>
      <country>Taiwan, Province Of China</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Hen-Hong Chang</name>
      <address>NO.123, Dinghu Rd., Guishan Township, Taoyuan County 333, Taiwan, R.O.C.</address>
      <phone>+886-3-3196200#2676</phone>
      <fax>+886-3-3294841</fax>
      <email>tcmchh@mail.cgu.edu.tw</email>
      <country>Taiwan, Province Of China</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>